APA

Long G. V., Saw R. P. M., Lo S., Nieweg O. E., Shannon K. F., Gonzalez M., Guminski A., Lee J. H., Lee H., Ferguson P. M., Rawson R. V., Wilmott J. S., Thompson J. F., Kefford R. F., Ch'ng S., Stretch J. R., Emmett L., Kapoor R., Rizos H., Spillane A. J., Scolyer R. A. & Menzies A. M. (20200622). Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF. : The Lancet. Oncology.

Chicago

Long Georgina V, Saw Robyn P M, Lo Serigne, Nieweg Omgo E, Shannon Kerwin F, Gonzalez Maria, Guminski Alexander, Lee Jenny H, Lee Hansol, Ferguson Peter M, Rawson Robert V, Wilmott James S, Thompson John F, Kefford Richard F, Ch'ng Sydney, Stretch Jonathan R, Emmett Louise, Kapoor Rony, Rizos Helen, Spillane Andrew J, Scolyer Richard A and Menzies Alexander M. 20200622. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF. : The Lancet. Oncology.

Harvard

Long G. V., Saw R. P. M., Lo S., Nieweg O. E., Shannon K. F., Gonzalez M., Guminski A., Lee J. H., Lee H., Ferguson P. M., Rawson R. V., Wilmott J. S., Thompson J. F., Kefford R. F., Ch'ng S., Stretch J. R., Emmett L., Kapoor R., Rizos H., Spillane A. J., Scolyer R. A. and Menzies A. M. (20200622). Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF. : The Lancet. Oncology.

MLA

Long Georgina V, Saw Robyn P M, Lo Serigne, Nieweg Omgo E, Shannon Kerwin F, Gonzalez Maria, Guminski Alexander, Lee Jenny H, Lee Hansol, Ferguson Peter M, Rawson Robert V, Wilmott James S, Thompson John F, Kefford Richard F, Ch'ng Sydney, Stretch Jonathan R, Emmett Louise, Kapoor Rony, Rizos Helen, Spillane Andrew J, Scolyer Richard A and Menzies Alexander M. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF. : The Lancet. Oncology. 20200622.